Abbott’s Volt PFA system gains FDA approval
MedTech Dive reports that Abbott has received FDA approval for its Volt pulsed field ablation system, a catheter based technology designed to treat atrial fibrillation. The system uses targeted electrical pulses to ablate cardiac tissue and is positioned as a minimally invasive option within the rapidly evolving electrophysiology space.
The approval marks an important milestone for Abbott as competition intensifies around pulsed field ablation technologies, which are gaining attention for their potential safety and procedural efficiency benefits compared to traditional ablation approaches.
🔗 Read the full article on MedTech Dive: Abbott receives FDA approval for Volt PFA system
Credit for images and content: MedTech Dive
____________________________________________________________________________________________________________________________________________________________________________________________________
Cure Talent is a recruitment agency dedicated to the medical technology industry. Whether you are looking for a new role in the medical device sector or you’re an innovative medical device, digital health, or biotech company looking for staff, get in touch with the team today and explore how Cure Talent can help!